Wake_Endocrine Profile Banner
Catherine Price, MD, ECNU, FACE Profile
Catherine Price, MD, ECNU, FACE

@Wake_Endocrine

Followers
333
Following
2K
Media
98
Statuses
287

Endocrinologist | She/Her | tweets = mine; retweet ≠ endorsement

Winston-Salem, NC
Joined April 2019
Don't wanna be here? Send us removal request.
@Wake_Endocrine
Catherine Price, MD, ECNU, FACE
5 months
RT @WFIMRes: Congratulations to all who matched!! We’re so excited for our next intern class! #Match2025
Tweet media one
0
1
0
@Wake_Endocrine
Catherine Price, MD, ECNU, FACE
5 months
Help support my ride for a cure @Advocacy_ADA
Tweet media one
0
0
1
@grok
Grok
8 days
Generate videos in just a few seconds. Try Grok Imagine, free for a limited time.
418
696
3K
@Wake_Endocrine
Catherine Price, MD, ECNU, FACE
6 months
Gratitude for working with such awesome humans at an amazing conference on Belonging in Healthcare @wakeforestmed @AtriumHealthWFB @advocatehealth #WakeEndo
Tweet media one
0
0
3
@Wake_Endocrine
Catherine Price, MD, ECNU, FACE
6 months
RT @ADA_DiabetesPro: Join the ADA on Feb 20, 4:00 PM ET & Learn how to interpret CGM data, optimize treatment plans, & master documentation….
0
1
0
@Wake_Endocrine
Catherine Price, MD, ECNU, FACE
7 months
Looking forward to this opportunity to educate others on utilization of CGM data.
@ADA_DiabetesPro
American Diabetes Association - DiabetesPro
7 months
Join the ADA on Feb 20, 4:00 PM ET & Learn how to interpret CGM data, optimize treatment plans, & master documentation & billing from experts Catherine Price, MD, ECNU, FACE @Wake_Endocrine, Carrie Keyes, PA-C, & Anyanate Gwendolyne Jack, MD. Register here
Tweet media one
0
0
2
@Wake_Endocrine
Catherine Price, MD, ECNU, FACE
8 months
RT @GoggleDocs: Barriers to insulin-treated #type2diabetes management using #CGM in UK primary care identified:. 🔹 Resistance to change amo….
0
5
0
@Wake_Endocrine
Catherine Price, MD, ECNU, FACE
8 months
Excellent update on clinically high impact areas of Endocrinology given today for the biannual update by @miya_mck and @Usoh_Endocrine @wakeforestmed @AtriumHealthWFB #WakeEndo
Tweet media one
0
0
8
@Wake_Endocrine
Catherine Price, MD, ECNU, FACE
9 months
Hot off the press: block and replace strategy for management of hypercortisolism in patient with metastatic adrenal cortical carcinoma @wakeforestmed @AtriumHealthWFB
Tweet media one
1
1
10
@Wake_Endocrine
Catherine Price, MD, ECNU, FACE
9 months
RT @ADA_DiabetesPro: Get ready for our upcoming webinar on #MASLD / #MASH management! On Nov 20, @JonathanStineMD, Kerry Sivia, & Dr. @Shel….
0
1
0
@Wake_Endocrine
Catherine Price, MD, ECNU, FACE
9 months
Excellent talks today by @EndoDocsRock and @miya_mck at the 26th annual @wakeforestmed Diabetes Management Conference 👏 #WakeEndo @AtriumHealthWFB
Tweet media one
Tweet media two
0
0
1
@Wake_Endocrine
Catherine Price, MD, ECNU, FACE
10 months
Great news for those with iPhones and on Omnipod.
@diaTribeNews
The diaTribe Foundation
10 months
🚨 Breaking News! The Omnipod 5 App for iPhone is now available. Read all the details here: #Omnipod5 #DiabetesTech
Tweet media one
0
0
3
@Wake_Endocrine
Catherine Price, MD, ECNU, FACE
10 months
Beautiful day for the #breakthroughT1DNC walk raising awareness and funds for #T1Diabetes @BreakthroughT1D with team #WakeEndo @wakeforestmed @AtriumHealthWFB
Tweet media one
0
2
2
@Wake_Endocrine
Catherine Price, MD, ECNU, FACE
10 months
RT @Drhkakturk: We showed 1-year glycemic control and safety data of insulin pump naive older adults with #type1diabetes who initiated auto….
Tweet card summary image
pubmed.ncbi.nlm.nih.gov
Long-term glycaemic improvement with the initiation of an automated insulin delivery system in insulin pump-naïve older adults with type 1 diabetes
0
2
0
@Wake_Endocrine
Catherine Price, MD, ECNU, FACE
10 months
Excellent IM grand rounds today on Inpatient DM Management by @ArchanaSadhu at @AtriumHealthWFB @wakeforestmed #WakeEndo
Tweet media one
0
0
7
@Wake_Endocrine
Catherine Price, MD, ECNU, FACE
11 months
Looking forward to this session on CGM with @josephaloi.
@ADA_DiabetesPro
American Diabetes Association - DiabetesPro
11 months
Join us for the latest installment in the Hands-On: Tips to Improve Diabetes Care webinar series on October 8th. This one-hour session, "Expanding CGM Use in your Clinical Practice," Register today:
Tweet media one
0
0
1
@Wake_Endocrine
Catherine Price, MD, ECNU, FACE
11 months
Way to go Peds Endo Dr. Walsh at @AtriumHealthWFB @wakeforestmed along with CDCES Paige Johnson and Sarah Rush for upcoming discussion on T2DM in pediatrics. #WakeEndo.
@ADA_DiabetesPro
American Diabetes Association - DiabetesPro
11 months
Next topic, Management of Pediatric Type 2 Diabetes: A Case Study. Live TODAY, October 1, 1:30-3:00 p.m. ET. Can’t make it, all webinars will be available on-demand. Earn 1.5 free CE credits per webinar. Sign Up Today!.
Tweet media one
0
0
0
@Wake_Endocrine
Catherine Price, MD, ECNU, FACE
11 months
Exciting study results for those living with #T1Diabetes.
@DrSamuelBHume
Samuel Hume
11 months
Biggest medical discoveries of the week (🧵). 1/10. The world's first autologous stem cell transplant for type 1 diabetes, in a 25-yo woman. After 1 year, she was independent from insulin, with improved blood sugar control. (Study:
Tweet media one
0
0
1
@Wake_Endocrine
Catherine Price, MD, ECNU, FACE
11 months
Another CGM option. Also looking forward to seeing this in the US.
@Drhkakturk
Dr. Halis Kaan Akturk
11 months
Roche to launch new CGM in Europe in ‘coming weeks’ | MedTech Dive.Roche CGM will be using machine learning to detect trends and hypoglycemia at night. Looking forward to seeing in the US #type1diabetes
0
0
0
@Wake_Endocrine
Catherine Price, MD, ECNU, FACE
11 months
RT @EricTopol: Microplastic pollution is an environmental and public health crisis, with little action being taken. A new @ScienceMagazine….
0
475
0
@Wake_Endocrine
Catherine Price, MD, ECNU, FACE
11 months
RT @Drhkakturk: Eversense 365 Receives FDA Clearance: The World’s First One Year CGM | Business Wire.One sensor for for year for #type1diab….
Tweet card summary image
businesswire.com
Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuo...
0
11
0